| No. | Date | Agendas | Pass/Fail | Participation |
|---|---|---|---|---|
| 4 | 03/28/2024 | 1. Inauguration of CEO | Approved | 5/6 |
| 3 | 03/21/2024 | 1. Investment in Magok R&D Center | Approved | 6/6 |
| 2 | 03/08/2024 | 1. Approval of separate financial statement and consolidated financial statement | Approved | 6/6 |
| 1 | 02/26/2024 | 1. Confirmation of general meeting of stockholders and agendas 2. Approve Allotment 3. Approval of corporate bond issuance limit |
Approved | 5/6 |
| No. | Date | Agendas | Pass/Fail | Participation |
|---|---|---|---|---|
| 5 | 10/27/2023 | 1. Investment in another corporation | Approved | 4/6 |
| 4 | 07/27/2023 | 1. The establishment of Daweoong Group ESG Committee | Approved | 6/6 |
| 3 | 05/02/2023 | 1. Approval of concurrent position of CEO 2. Approval of facility(Nabota) investment |
Approved | 6/6 |
| 2 | 04/12/2023 | 1. Designation of Authorized Representative | Approved | 5/6 |
| 1 | 03/08/2023 | 1. Approval of separate financial statement and consolidated financial statement 2. Confirmation of general meeting of stockholders and agendas 3. Stock Dispositions 4. Approval of concurrent position of CEO |
Approved | 5/6 |
| No. | Date | Agendas | Pass/Fail | Participation |
|---|---|---|---|---|
| 6 | 10/28/2022 | Reports | Approved | 4/6 |
| 5 | 10/07/2022 | Cash loan to Employee Stock Ownership Union | Approved | 5/6 |
| 4 | 07/28/2022 | Reports | Approved | 6/6 |
| 3 | 05/09/2022 | Reports | Approved | 5/6 |
| 2 | 03/08/2022 | 1. Approval of separate financial statement and consolidated financial statement 2. Confirmation of general meeting of stockholders and agendas 3. Amendment of Board of Directors regulation 4. Approval of EHS (Environment, Safety, Health) plan |
Approved | 4/5 |
| 1 | 01/03/2022 | Inauguration of CEO | Approved | 4/5 |
| No. | Date | Agendas | Pass/Fail | Participation |
|---|---|---|---|---|
| 6 | 10/26/2021 | Reports | Approved | 5/5 |
| 5 | 07/07/2021 | Issuing of public corporate bonds(15th, KRW 90 Bil. Won) | Approved | 5/5 |
| 4 | 05/06/2021 | Approval of safety & health plan 2021 | Approved | 3/5 |
| 3 | 03/26/2021 | Inauguration of CEO | Approved | 5/5 |
| 2 | 03/18/2021 | Stock Dispositions | Approved | 2/3 |
| 1 | 03/11/2021 | 1. Induction of electronic voting 2. Approval of separate financial statement and consolidated financial statement 3. Confirmation of general meeting of stockholders and agendas |
Approved | 3/3 |
| No. | Date | Agendas | Pass/Fail | Participation |
|---|---|---|---|---|
| 7 | 10/21/2020 | Financing (funding) | Approved | 3/3 |
| 6 | 07/30/2020 | Established internal accounting rules and auditor occupational rules | Approved | 3/3 |
| 5 | 07/07/2020 | Acquired convertible bond rights | Approved | 2/3 |
| 4 | 05/07/2020 | Established the ion-channel platform VITVO and allowed the concurrent position of CEO | Approved | 3/3 |
| 3 | 03/23/2020 | Stock Dispositions | Approved | 2/3 |
| 2 | 03/05/2020 | Approval of separate financial statement and consolidated financial statement | Approved | 4/4 |
| 1 | 02/27/2020 | Confirmation of general meeting of stockholders and agendas | Approved | 4/4 |
| No. | Date | Agendas | Pass/Fail | Participation |
|---|---|---|---|---|
| 5 | 10/18/2019 | Issuing of corporate bonds | Approved | 3/4 |
| 4 | 10/18/2019 | Approval for issuing of corporate bonds | Approved | 3/4 |
| 3 | 4/11/2019 | Issuing of corporate bonds | Approved | 3/4 |
| 2 | 3/7/2019 | Approval of separate financial statement and consolidated financial statement | Approved | 3/4 |
| 1 | 3/6/2019 | 1. Confirmation of general meeting of stockholders and agendas 2. Granting of stock options 3. Investment in Magok District |
Approved | 4/4 |
| No. | Date | Agendas | Pass/Fail | Participation |
|---|---|---|---|---|
| 4 | 9/21/2018 | 1. Granting of stock options 2. Approval of anti-corruption policies |
Approved | 3/4 |
| 3 | 7/6/2018 | 1. Issuing of corporate bonds | Approved | 4/4 |
| 2 | 3/23/2018 | 1. Inauguration of CEO 2. Change of HQ address |
Approved | 3/4 |
| 1 | 2/28/2018 | 1. Confirmation of general meeting of stockholders and agendas 2. Approval of 16th separate financial statement and consolidated financial statement |
Approved | 1/1 |